🎉 M&A multiples are live!
Check it out!

Biome Australia Valuation Multiples

Discover revenue and EBITDA valuation multiples for Biome Australia and similar public comparables like Mega Lifesciences, SynBiotic, and Abbott India.

Biome Australia Overview

About Biome Australia

Biome Australia Ltd licences, develops, and markets evidence-based, complementary medicines, including nutraceuticals food-based vitamins and weight management products and live biotherapeutics. The firm owns brands namely; Activated Nutrients: a range of completely organic, plant-based, all-in-one nutritional products; Activated Probiotics: a first-of-its-kind range of clinically-backed precision probiotics. The company has one operating segment: researching, developing, manufacturing and distributing innovative evidence-based products linking the gut and human health. Domestically it caters to Australia and In international markets, the Group distributes and markets its Activated Probiotics range in the United Kingdom and New Zealand through independent health practitioners.


Founded

2018

HQ

Australia
Employees

30

Financials

LTM Revenue $13.3M

LTM EBITDA $0.8M

EV

$68.9M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Biome Australia Financials

As of August 2025, Biome Australia reported last 12-month revenue of $13.3M and EBITDA of $0.8M.

In the same period, Biome Australia generated $8.1M in LTM gross profit and $0.6M in net income.

See Biome Australia valuation multiples based on analyst estimates

Biome Australia P&L

In the most recent fiscal year, Biome Australia reported revenue of $8.5M and EBITDA of -$0.8M.

Biome Australia expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Biome Australia valuation multiples based on analyst estimates
LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue $13.3M XXX $8.5M XXX XXX XXX
Gross Profit $8.1M XXX $5.2M XXX XXX XXX
Gross Margin 61% XXX 61% XXX XXX XXX
EBITDA $0.8M XXX -$0.8M XXX XXX XXX
EBITDA Margin 6% XXX -10% XXX XXX XXX
EBIT $0.7M XXX -$1.3M XXX XXX XXX
EBIT Margin 5% XXX -15% XXX XXX XXX
Net Profit $0.6M XXX -$1.1M XXX XXX XXX
Net Margin 5% XXX -13% XXX XXX XXX
Net Debt XXX XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Biome Australia Stock Performance

Biome Australia has current market cap of AUD 105M (or $68.7M), and EV of AUD 105M (or $68.9M).

Market Cap Evolution

Biome Australia Stock Data

As of September 19, 2025, Biome Australia's stock price is AUD 0 (or $0).

See Biome Australia trading valuation data
EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$68.9M $68.7M XXX XXX XXX XXX $0.00

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Biome Australia Valuation Multiples

Biome Australia's trades at 10.4x EV/Revenue multiple, and -52.0x EV/EBITDA.

See valuation multiples for Biome Australia and 15K+ public comps

Biome Australia Financial Valuation Multiples

As of September 19, 2025, Biome Australia has market cap of $68.7M and EV of $68.9M.

Equity research analysts estimate Biome Australia's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Biome Australia has a P/E ratio of 113.7x.

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $68.7M XXX $68.7M XXX XXX XXX
EV (current) $68.9M XXX $68.9M XXX XXX XXX
EV/Revenue 5.2x XXX 10.4x XXX XXX XXX
EV/EBITDA 83.8x XXX -52.0x XXX XXX XXX
EV/EBIT 104.1x XXX -39.8x XXX XXX XXX
EV/Gross Profit 8.5x XXX n/a XXX XXX XXX
P/E 113.7x XXX -44.1x XXX XXX XXX
EV/FCF -61.8x XXX -51.5x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Biome Australia Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Biome Australia Margins & Growth Rates

Biome Australia's last 12 month revenue growth is 43%

Biome Australia's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.

Biome Australia's rule of 40 is 23% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Biome Australia's rule of X is 113% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Biome Australia and other 15K+ public comps

Biome Australia Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth 43% XXX 77% XXX XXX XXX
EBITDA Margin 6% XXX -20% XXX XXX XXX
EBITDA Growth 282% XXX n/a XXX XXX XXX
Rule of 40 23% XXX 23% XXX XXX XXX
Bessemer Rule of X XXX XXX 113% XXX XXX XXX
Revenue per Employee XXX XXX $0.3M XXX XXX XXX
Opex per Employee XXX XXX $0.2M XXX XXX XXX
S&M Expenses to Revenue XXX XXX 22% XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX n/a XXX XXX XXX
Opex to Revenue XXX XXX 76% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Biome Australia Public Comps

See public comps and valuation multiples for Nutraceuticals & Cosmeceuticals comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Vita Life Sciences XXX XXX XXX XXX XXX XXX
SynBiotic XXX XXX XXX XXX XXX XXX
Mega Lifesciences XXX XXX XXX XXX XXX XXX
Procter & Gamble Health XXX XXX XXX XXX XXX XXX
Abbott India XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Biome Australia M&A and Investment Activity

Biome Australia acquired  XXX companies to date.

Last acquisition by Biome Australia was  XXXXXXXX, XXXXX XXXXX XXXXXX . Biome Australia acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Biome Australia

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.

Start Free Trial

About Biome Australia

When was Biome Australia founded? Biome Australia was founded in 2018.
Where is Biome Australia headquartered? Biome Australia is headquartered in Australia.
How many employees does Biome Australia have? As of today, Biome Australia has 30 employees.
Is Biome Australia publicy listed? Yes, Biome Australia is a public company listed on ASX.
What is the stock symbol of Biome Australia? Biome Australia trades under BIO ticker.
When did Biome Australia go public? Biome Australia went public in 2021.
Who are competitors of Biome Australia? Similar companies to Biome Australia include e.g. Vita Life Sciences, SynBiotic, Mega Lifesciences, Procter & Gamble Health.
What is the current market cap of Biome Australia? Biome Australia's current market cap is $68.7M
What is the current revenue of Biome Australia? Biome Australia's last 12 months revenue is $13.3M.
What is the current revenue growth of Biome Australia? Biome Australia revenue growth (NTM/LTM) is 43%.
What is the current EV/Revenue multiple of Biome Australia? Current revenue multiple of Biome Australia is 5.2x.
Is Biome Australia profitable? Yes, Biome Australia is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Biome Australia? Biome Australia's last 12 months EBITDA is $0.8M.
What is Biome Australia's EBITDA margin? Biome Australia's last 12 months EBITDA margin is 6%.
What is the current EV/EBITDA multiple of Biome Australia? Current EBITDA multiple of Biome Australia is 83.8x.
What is the current FCF of Biome Australia? Biome Australia's last 12 months FCF is -$1.1M.
What is Biome Australia's FCF margin? Biome Australia's last 12 months FCF margin is -8%.
What is the current EV/FCF multiple of Biome Australia? Current FCF multiple of Biome Australia is -61.8x.

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.